Chr Hansen A/S : Q4 Factsheet 2020/21

Factsheet

Q4 2020/21

		Q4	Q4		YTD	YTD
		19/20	20/21	19/20	20/21
Income statement, continuing operations (EUR m)
Revenue	254.3	293.3	970.0	1,077.4
Gross profit	156.7	169.4	584.0	613.4
EBITDA b.s.i.	121.0	111.8	400.6	399.3
EBIT b.s.i.	97.7	84.2	326.9	298.1
EBIT	88.9	84.1	313.0	276.2
Net financial items	(4.3)	(6.4)	(13.5)	(22.5)
Group profit for the period	66.2	69.2	245.0	845.2
Cash flow and investments, continuing operations (EUR m)
Operating cash flow	123.9	135.0	329.8	328.0
Operational investing cash flow	(51.3)	(58.6)	(118.8)	(153.5)
M&A	(537.8)	-	(657.2)	(318.2)
Free cash flow b.s.i.a.d.	81.4	76.5	224.9	196.4
Balance sheet, Group (EUR m)
Total assets			2,853.6	3,114.2
Invested capital			2,487.6	2,793.1
Net working capital			208.1	190.1
Equity			893.0	1,626.1
Net interest-bearing debt			1,345.0	898.2
Key ratios (%)
Continuing operations
Gross margin	61.6%	57.8%	60.2%	56.9%
EBITDA margin b.s.i.	47.6%	38.1%	41.3%	37.1%
EBIT margin b.s.i	38.4%	28.8%	33.7%	27.7%
Underlying EBIT b.s.i. margin1	38.2%	32.6%	33.6%	31.4%
R&D	6.7%	8.6%	8.0%	8.5%
Capex	20.2%	20.0%	12.2%	14.5%
ROIC excl. goodwill	38.1%	25.8%	33.6%	24.8%
ROIC	18.8%	12.0%	16.5%	11.6%
Net debt to EBITDA b.s.i.				3.1x	2.3x
Revenue split by
Revenue split by
business, YTD	region, YTD

	APAC
	18%
H&N	EMEA
35%
39%

LATAM 12%

FC&E

65%

						---
						______
		Q4	Q4		YTD	YTD
	19/20	20/21	19/20	20/21
Growth drivers, continuing operations (%)
Organic growth	9%	6%	6%	7%
Volume/mix	5%	4%	4%	3%
Price	4%	2%	2%	4%
Currencies	-6%	-3%	-3%	-7%
M&A	<1%	12%	0%	11%
EUR growth	3%	15%	3%	11%

Organic growth by region, continuing operations (%)

EMEA	3%	11%	3%	6%
NA	1%	4%	4%	6%
LATAM	47%	15%	24%	26%
APAC	10%	-10%	6%	-3%
Food Cultures & Enzymes (EUR m / %)
Revenue	173.3	185.9	693.1	700.5
Organic growth	5%	10%	5%	8%
Volume/mix	0%	8%	3%	3%
Currencies	-8%	-3%	-3%	-7%
M&A	-	-	-	-
EUR growth	-3%	7%	2%	1%
EBITDA b.s.i.	79.1	76.3	285.2	277.7
EBITDA margin b.s.i.	45.6%	41.0%	41.1%	39.6%
EBIT b.s.i.	66.7	61.4	237.8	224.0
EBIT margin b.s.i.	38.4%	33.0%	34.3%	32.0%
ROIC excl. goodwill				41.1%	35.8%
Health & Nutrition (EUR m / %)
Revenue	81.0	107.4	276.9	376.9
Organic growth	18%	-4%	9%	5%
Volume/mix	19%	-7%	10%	3%
Currencies	-6%	-2%	-1%	-6%
M&A	>2%	39%	1%	37%
EUR growth	15%	33%	9%	36%
EBITDA b.s.i.	41.9	35.9	115.4	122.0
EBITDA margin b.s.i.	51.7%	33.4%	41.7%	32.4%
EBIT b.s.i.	31.0	23.2	89.1	74.5
EBIT margin b.s.i.	38.3%	21.6%	32.2%	19.8%
Underlying EBIT margin b.s.i.1	37.5%	32.1%	31.9%	30.0%
ROIC excl. goodwill				22.6%	13.0%

1 See Q4 2020/21 company announcement, p. 22, for reconciliation of underlying margins.

NA

31%